S. Anderson

发表

Impaired adaptation to renal mass reduction in the polycystic rat.

S. Kang, T. Oyama, T. M. Kennefick, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Hypertension and renal injury in experimental polycystic kidney disease.

S Anderson, T. Oyama, T. M. Kennefick, 1999, Kidney international.

Glomerular filtrate proteins in acute cardiorenal syndrome.

Richard D. Smith, P. Piehowski, K. Rodland, 2019, JCI insight.

Treatment of hypertension in diabetic patients with nephropathy

R. Komers, S. Anderson, 2001, Current diabetes reports.

Are angiotensin-converting enzyme inhibitors the best treatment for hypertension in type 2 diabetes?

R. Komers, S. Anderson, 2000, Current opinion in nephrology and hypertension.

Pathogenesis of glomerular injury in the fawn-hooded rat: early glomerular capillary hypertension predicts glomerular sclerosis.

J. L. Simons, B. Brenner, S. Anderson, 1993, Journal of the American Society of Nephrology : JASN.

Estrogen-Mediated Renoprotection following Cardiac Arrest and Cardiopulmonary Resuscitation Is Robust to GPR30 Gene Deletion

S. Anderson, N. Alkayed, S. Murphy, 2014, PloS one.

Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo.

R. Komers, S. Anderson, P. Herson, 2012, American journal of physiology. Renal physiology.

Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury.

J. L. Simons, B. Brenner, S. Anderson, 1994, Kidney international.

Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease.

Y. G. Kim, J. Hughes, T. Oyama, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

S. Mader, T. Oyama, S. Anderson, 2011, Vascular pharmacology.

Reversing glomerular hypertension stabilizes established glomerular injury.

B. Brenner, T. Meyer, S. Anderson, 1987, Kidney international.

Determination of renal function and injury using near-infrared fluorimetry in experimental cardiorenal syndrome.

H. Choi, S. Anderson, Jeong Heon Lee, 2017, American journal of physiology. Renal physiology.

Scientists' statement regarding data on the sodium-hypertension relationship and sodium health claims on food labeling.

R. Haynes, S. Oparil, J. Laragh, 1997, Nutrition reviews.

Dietary protein intake and progressive glomerular sclerosis: the role of capillary hypertension and hyperperfusion in the progression of renal disease.

B. Brenner, T. Meyer, S. Anderson, 1983, Annals of internal medicine.

Relevance of single nephron studies to human glomerular function.

S. Anderson, 1994, Kidney international.

Glomerular preload and afterload reduction as a tool to lower urinary protein leakage: will such treatments also help to improve renal function outcome?

D. de Zeeuw, P. D. de Jong, S. Anderson, 1993, Journal of the American Society of Nephrology : JASN.

Antihypertensive therapy in experimental diabetes.

S. Anderson, 1992, Journal of the American Society of Nephrology : JASN.

Gender hormones and the progression of experimental polycystic kidney disease.

R. Komers, T. Oyama, S. Anderson, 2005, Kidney international.

Influence of Antihypertensive Therapy on Development and Progression of Diabetic Glomerulopathy

B. Brenner, S. Anderson, 1988, Diabetes Care.

Inhibition of the renin-angiotensin system: is more better?

R. Komers, S. Anderson, 2009, Kidney international.

Effects of cyclooxygenase-2 (COX-2) inhibition on plasma and renal renin in diabetes.

R. Komers, T. Oyama, S. Anderson, 2002, The Journal of laboratory and clinical medicine.

32. PAmOGENESIS OF DIABETIC GWMERUWPATHY: mE ROLE OF GLOMERULAR HEMODYNAMIC FACTORS

S. Anderson, 1998 .

Pathogenesis of Diabetic Glomerulopathy: The Role of Glomerular Hemodynamic Factors

R. Komers, S. Anderson, 1994 .

The aging kidney: physiological changes.

S. Anderson, J. Weinstein, Sharon Anderson, 2010, Advances in chronic kidney disease.

Altered renal vascular responses in the aging rat kidney.

S. Anderson, J. Vora, D. Houghton, 1994, The American journal of physiology.

Down-regulation of the intrarenal renin-angiotensin system in the aging rat.

J. Ingelfinger, T. M. Kennefick, S. Anderson, 1995, Journal of the American Society of Nephrology : JASN.

Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia.

S. E. Thomas, T. Oyama, S. Anderson, 1998, Journal of the American Society of Nephrology : JASN.

The role of intraglomerular pressure in the initiation and progression of renal disease.

B. Brenner, S. Anderson, Barry M. Brenner, 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Aliskiren combined with losartan in diabetes and nephropathy.

R. Komers, S. Anderson, 2008, The New England journal of medicine.

Pathogenesis of Diabetic Glomerulopathy: The Role of Glomerular Hyperfiltration

B. Brenner, S. Anderson, 1988 .

Pathogenesis of glomerular injury in the fawn-hooded rat: effect of unilateral nephrectomy.

J. L. Simons, B. Brenner, S. Anderson, 1993, Journal of the American Society of Nephrology : JASN.

Renal cyclooxygenase-2 in obese Zucker (fatty) rats.

R. Komers, S. Anderson, L. Kazdová, 2005, Kidney international.

Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure.

R. Komers, T. Oyama, S. Anderson, 2011, Kidney international.

Renal Activity of Akt Kinase in Obese Zucker Rats

R. Komers, S. Anderson, L. Kazdová, 2008, Experimental biology and medicine.

Nephron site of effect of nonsteroidal anti-inflammatory drugs on solute excretion in humans.

S. Anderson, D. Brater, S. Kaojarern, 1983, The American journal of physiology.

Hyperglycemia abolishes the protective effect of ischemic preconditioning in glomerular endothelial cells in vitro

S. Anderson, N. Alkayed, M. Hutchens, 2015, Physiological reports.

Renal expression of osmotically responsive cation channel TRPV4 is restricted to water-impermeant nephron segments.

T. Oyama, S. Anderson, D. Cohen, 2004, American journal of physiology. Renal physiology.

The interrelationships among filtration surface area, blood pressure, and chronic renal disease.

B. Brenner, S. Anderson, 1992, Journal of cardiovascular pharmacology.

Atrial natriuretic peptide transcription, storage, and release in rats with myocardial infarction.

J. Seidman, B. Brenner, S. Anderson, 1987, The American journal of physiology.

Effects of systemic inhibition of Rho kinase on blood pressure and renal haemodynamics in diabetic rats

R. Komers, T. Oyama, S. Anderson, 2011, British journal of pharmacology.

Acute and Chronic Renal Effects of Recombinant Human TGF-β2 in the Rat

C. Corless, S. Ledbetter, T. Oyama, 1999 .

Role of local and systemic angiotensin in diabetic renal disease.

S. Anderson, 1997, Kidney international. Supplement.

Optimal strategies for preventing progression of renal disease: Should angiotensin converting enzyme inhibitors and angiotensin receptor blockers be used together?

R. Komers, S. Anderson, 2000, Current hypertension reports.

Role of atrial natriuretic peptide in adaptation of sodium excretion with reduced renal mass.

B. Brenner, B. Ballermann, S. Anderson, 1986, The Journal of clinical investigation.

Anemia ameliorates progressive renal injury in experimental DOCA-salt hypertension.

B. Brenner, S. Anderson, H. Rennke, 1991, Journal of the American Society of Nephrology : JASN.

Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.

R. Komers, T. Oyama, S. Anderson, 2007, Translational research : the journal of laboratory and clinical medicine.

Role of altered capillary hemodynamics in the initiation and progression of diabetic microangiopathy.

B. Brenner, S. Anderson, 1988, The Journal of diabetic complications.

Current concepts of renal hemodynamics in diabetes.

S. Anderson, J. Vora, J. Vora, 1995, Journal of diabetes and its complications.

Nitric oxide: a potential mediator of amino acid-induced renal hyperemia and hyperfiltration.

B. Brenner, S. Anderson, A. King, 1991, Journal of the American Society of Nephrology : JASN.

Endothelin: a potent renal and systemic vasoconstrictor peptide.

B. Brenner, S. Anderson, A. King, 1989, The American journal of physiology.

Activity and responsiveness of the renin-angiotensin system in the aging rat.

T. Oyama, T. M. Kennefick, M. Thompson, 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

Evolution of metabolic and renal changes in the ZDF/Drt-fa rat model of type II diabetes.

S. Anderson, J. Vora, D. Houghton, 1996, Journal of the American Society of Nephrology : JASN.

CYCLO‐OXYGENASE‐2 INHIBITION ATTENUATES THE PROGRESSION OF NEPHROPATHY IN UNINEPHRECTOMIZED DIABETIC RATS

R. Komers, T. Oyama, S. Anderson, 2007, Clinical and experimental pharmacology & physiology.

Glomerular function in diabetes mellitus.

B. Brenner, S. Anderson, 1990, Advances in nephrology from the Necker Hospital.

Effects of long-term inhibition of neuronal nitric oxide synthase (NOS1) in uninephrectomized diabetic rats.

R. Komers, T. Oyama, S. Anderson, 2004, Nitric oxide : biology and chemistry.

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.

B. Brenner, S. Anderson, H. Rennke, 1986, The Journal of clinical investigation.

Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes.

S. Mader, R. Komers, T. Oyama, 2001, The Journal of clinical investigation.

Lowering of arterial blood pressure limits glomerular sclerosis in rats with renal ablation and in experimental diabetes.

B. Brenner, T. Meyer, S. Anderson, 1987, Kidney international. Supplement.

Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes.

R. Komers, T. Oyama, S. Anderson, 2000, American journal of physiology. Renal physiology.

Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors.

R. Komers, S. Anderson, M. Epstein, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Women in Nephrology Leadership.

S. Anderson, W. Brown, 2018, Advances in chronic kidney disease.

Altered Endothelial Nitric Oxide Synthase Targeting and Conformation and Caveolin-1 Expression in the Diabetic Kidney

S. Mader, R. Komers, T. Oyama, 2006, Diabetes.

Acute and Chronic Renal Effects of Recombinant Human TGF- b 2 in the Rat

C. Corless, S. Ledbetter, T. Oyama, 2000 .

Effects of systemic inhibition of neuronal nitric oxide synthase in diabetic rats.

R. Komers, T. Oyama, S. Anderson, 2000, Hypertension.

Reversing glomerular hypertension stabilizes established glomerular injury in renal ablation.

B. Brenner, T. Meyer, S. Anderson, 1986, Journal of Hypertension - Supplement.

Renal p38 MAP kinase activity in experimental diabetes

R. Komers, T. Oyama, S. Anderson, 2007, Laboratory Investigation.

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.

B. Brenner, T. Meyer, S. Anderson, 1986, The Journal of clinical investigation.

Acute and chronic renal effects of recombinant human TGF-beta2 in the rat.

C. Corless, S. Ledbetter, T. Oyama, 1999, Journal of the American Society of Nephrology : JASN.

Bone resorption and "relative" immobilization hypercalcemia with prolonged continuous renal replacement therapy and citrate anticoagulation.

S. Anderson, S. Orloff, M. Meyer, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Prevention of progressive chronic renal failure

S. Anderson, A. M. Nahas, N. Mallick, 1993 .

Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions.

D. de Zeeuw, S. Anderson, W. Keane, 1989, Annals of internal medicine.

Progressive renal disease: a disorder of adaptation.

B. Brenner, S. Anderson, 1989, The Quarterly journal of medicine.

Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass.

B. Brenner, S. Anderson, H. Rennke, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Functional effects of nonsynonymous polymorphisms in the human TRPV1 gene.

T. Oyama, S. Anderson, D. Cohen, 2007, American journal of physiology. Renal physiology.

The hemodynamic basis of progressive renal disease.

B. Brenner, S. Anderson, B. R. Dunn, 1986, Seminars in nephrology.

Prediction, progression, and outcomes of chronic kidney disease in older adults.

J. Halter, K. Schmader, J. Kusek, 2009, Journal of the American Society of Nephrology : JASN.

The role of hemodynamic factors in the initiation and progression of renal disease.

B. Brenner, T. Meyer, S. Anderson, 1985, The Journal of urology.

Elevated plasma atrial natriuretic peptide levels in diabetic rats. Potential mediator of hyperfiltration.

B. Brenner, B. Ballermann, S. Anderson, 1987, The Journal of clinical investigation.

p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levels

Jin-Young Park, R. Weiss, T. Oyama, 2007, BMC nephrology.

p 21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression : roscovitine augments p 21 levels

Jin-Young Park, R. Weiss, T. Oyama, 2007 .

2-Hydroxyestradiol slows progression of experimental polycystic kidney disease.

R. Komers, V. Gattone, T. Oyama, 2012, American journal of physiology. Renal physiology.

Calcium Balance and Parathyroid Hormone Mediated Vasodilation in the Spontaneously Hypertensive Rat

D. Ellison, S. Anderson, James R. Grady, 1983, Hypertension.

K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease

Bruce Kupelnick, Nathan W. Levin, Roger Greenwood, 2004 .

Ageing and the renin-angiotensin system.

S. Anderson, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.

B. Brenner, T. Meyer, S. Anderson, 1985, The Journal of clinical investigation.

Nifedipine versus fosinopril in uninephrectomized diabetic rats.

B. Brenner, S. Anderson, H. Rennke, 1992, Kidney international.

Acute kidney injury in older adults.

J. Halter, P. Kimmel, K. Schmader, 2011, Journal of the American Society of Nephrology : JASN.

Effects of aging on the renal glomerulus.

B. Brenner, S. Anderson, 1986, The American journal of medicine.

Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation.

B. Brenner, S. Anderson, H. Rennke, 1987, The Journal of clinical investigation.

Nephrology/Fluid and Electrolyte Disorders

S. Anderson, 1997 .

Nephrology IFluid and Electrolyte Disorders

S. Anderson, 1990 .

Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome.

B. Brenner, S. Anderson, M. Karnovsky, 1988, The Journal of clinical investigation.

Paradoxes of nitric oxide in the diabetic kidney.

R. Komers, S. Anderson, 2003, American journal of physiology. Renal physiology.

Role of the microvascular endothelium in progressive renal disease.

L. Truong, S. Anderson, D. Kerjaschki, 2002, Journal of the American Society of Nephrology : JASN.

Short and long term effects of antihypertensive therapy in the diabetic rat.

B. Brenner, S. Anderson, H. Rennke, 1989, Kidney international.

Physiologic Actions and Molecular Expression of the Renin-Angiotensin System in the Diabetic Rat

S. Anderson, 1998, Mineral and Electrolyte Metabolism.

Glomerular adaptations with normal aging and with long-term converting enzyme inhibition in rats.

S. Anderson, H. Rennke, R. Zatz, 1994, The American journal of physiology.

Anemia: a potent modulator of renal hemodynamics in models of progressive renal disease.

B. Brenner, S. Anderson, H. Lafferty, 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Renal hemodynamic and natriuretic effects of manganese and interactions with atrial natriuretic peptide.

B. Brenner, S. Anderson, H. Brady, 1990, The American journal of physiology.

Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations.

J. Ingelfinger, S. Anderson, F. Jung, 1993, The American journal of physiology.

Mechanisms of age-associated glomerular sclerosis

B. Brenner, T. Meyer, S. Anderson, 1987 .

Decline of Renal Function with Age: Mechanisms, Risk Factors and Therapeutic Implications

S. Anderson, 1986 .

Documentation and management of CKD in rural primary care.

Melinda M. Davis, M. Mori, S. Anderson, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Renal Hemodynamic Effects of Calcium Antagonists in Rats With Reduced Renal Mass

S. Anderson, 1991, Hypertension.

The Aging Kidney: Structure, Function, Mechanisms, and Therapeutic Implications

B. Brenner, S. Anderson, Barry M. Brenner, 1987, Journal of the American Geriatrics Society.

Converting enzyme inhibitor therapy limits progressive glomerular injury in rats with renal insufficiency.

B. Brenner, T. Meyer, S. Anderson, 1985, The American journal of medicine.

Estrogen Is Renoprotective via a Nonreceptor-dependent Mechanism after Cardiac Arrest In Vivo

S. Anderson, P. Hurn, S. Murphy, 2010, Anesthesiology.

Estrogen administered after cardiac arrest and cardiopulmonary resuscitation ameliorates acute kidney injury in a sex- and age-specific manner

S. Anderson, T. Lahm, M. Hutchens, 2015, Critical Care.

Interrelationships among atrial peptides, renin, and blood volume in pregnant rats.

B. Brenner, B. Ballermann, S. Anderson, 1988, The American journal of physiology.

Interactions of the Kallikrein-Kinin and Renin-Angiotensin Systems in Experimental Diabetes

T. Oyama, M. Thompson, S. Anderson, 1997, Diabetes.

Systemic and glomerular hypertension in progressive renal disease.

S. Anderson, Sharon Anderson, 1988, Kidney international. Supplement.

Pathogenesis of diabetic glomerulopathy: hemodynamic considerations.

B. Brenner, S. Anderson, 1988, Diabetes/metabolism reviews.

EphA2: expression in the renal medulla and regulation by hypertonicity and urea stress in vitro and in vivo.

C. Rivard, T. Oyama, S. Anderson, 2005, American journal of physiology. Renal physiology.

Endothelial-derived vasoactive mediators in polycystic kidney disease.

Sharon Anderson, A. Subramanya, R. Komers, 2003, Kidney international.

Enhanced renal sensitivity to angiotensin actions in diabetes mellitus in the rat.

T. Oyama, T. M. Kennefick, M. Thompson, 1996, The American journal of physiology.

Assessment of effort in clinical testing of cognitive functioning for adults

G. Baker, S. Anderson, T. McMillan, 2009 .

Effect of orchiectomy on renal function in control and diabetic rats with chronic inhibition of nitric oxide

R. Komers, T. Oyama, S. Anderson, 2010, Clinical and experimental pharmacology & physiology.

The Kidney in Aging

S. Anderson, Maya K. Rao, 2009 .

Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril

Robert W Platt, Sharon Anderson, Amanda F. Petrik, 2010, Pharmacoepidemiology and drug safety.

Intraglomerular hypertension: implications and drug treatment.

B. Brenner, S. Anderson, 1988, Annual review of medicine.

Prevention of glomerular capillary hypertension in experimental diabetes mellitus obviates functional and structural glomerular injury.

B. Brenner, T. Meyer, S. Anderson, 1986, Journal of Hypertension - Supplement.

Antihypertensive therapy and the progression of renal disease.

S. Anderson, 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Progression of chronic renal disease: role of systemic and glomerular hypertension.

S. Anderson, 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Low protein diets and diabetic nephropathy.

S. Anderson, 1990, Seminars in nephrology.

THE AGING KIDNEY: PHYSIOLOGICAL CHANGES

S. Anderson, J. Weinstein, 2022 .

Glomeruli and blood pressure. Less of one, more the other?

B. Brenner, S. Anderson, B M Brenner, 1988, American journal of hypertension.

Antihypertensive therapy must control glomerular hypertension to limit glomerular injury.

B. Brenner, S. Anderson, H. Rennke, 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Estrogen Is Renoprotective via a Nonreceptor-dependent Mechanism after Cardiac Arrest In Vivo

S. Anderson, P. Hurn, S. Murphy, 2010, Anesthesiology.

Acute kidney injury in older adults.

J. Halter, P. Kimmel, K. Schmader, 2011, Journal of the American Society of Nephrology : JASN.

Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo.

R. Komers, S. Anderson, P. Herson, 2012, American journal of physiology. Renal physiology.

Role of the microvascular endothelium in progressive renal disease.

L. Truong, S. Anderson, D. Kerjaschki, 2002, Journal of the American Society of Nephrology : JASN.

Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure.

R. Komers, T. Oyama, S. Anderson, 2011, Kidney international.

2-Hydroxyestradiol slows progression of experimental polycystic kidney disease.

R. Komers, V. Gattone, T. Oyama, 2012, American journal of physiology. Renal physiology.

EphA2: expression in the renal medulla and regulation by hypertonicity and urea stress in vitro and in vivo.

C. Rivard, T. Oyama, S. Anderson, 2005, American journal of physiology. Renal physiology.

Therapeutic benefit of converting-enzyme inhibition in progressive renal disease.

B. Brenner, S. Anderson, 1988, American journal of hypertension.

Vasodilation mediated by human PTH 1-34 in the spontaneously hypertensive rat.

D. Ellison, S. Anderson, D. McCarron, 1984, The American journal of physiology.

Renal Effects of Converting Enzyme Inhibitors in Hypertension and Diabetes

S. Anderson, 1990, Journal of cardiovascular pharmacology.

Enkephalinase Inhibition Increases Plasma Atrial Natriuretic Peptide Levels, Glomerular Filtration Rate, and Urinary Sodium Excretion in Rats With Reduced Renal Mass

B. Brenner, S. Anderson, M. B. Zimmerman, 1989, Circulation research.

Glomerular filtrate proteins in acute cardiorenal syndrome.

P. Piehowski, K. Rodland, S. Anderson, 2019, JCI insight.